About SCRI-CCCIT GesmbH ( Site 0371)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Merck Sharp & Dohme LLC
2
Clinical Trials at SCRI-CCCIT GesmbH ( Site 0371)
During the past decade, SCRI-CCCIT GesmbH ( Site 0371) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)
2019-05-02
2023-10-04
Active, not recruiting
1,090
Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010)
2019-05-02
2023-09-29
Active, not recruiting
793
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at SCRI-CCCIT GesmbH ( Site 0371)
According to Clinical.Site data, the most researched conditions in "SCRI-CCCIT GesmbH ( Site 0371)" are
"Prostatic Neoplasms" (2 trials). Many other conditions were trialed in "SCRI-CCCIT GesmbH ( Site 0371)" in a lesser frequency.
Clinical Trials Intervention Types at SCRI-CCCIT GesmbH ( Site 0371)
Most popular intervention types in "SCRI-CCCIT GesmbH ( Site 0371)" are "Biological" (2 trials) and "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Pembrolizumab" (2 trials), "Prednisone" (2 trials), "Abiraterone acetate" (1 trials), "Dexamethasone" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.
Clinical Trials Genders at SCRI-CCCIT GesmbH ( Site 0371)
The vast majority of trials in "SCRI-CCCIT GesmbH ( Site 0371)" are
2 trials for "Male" genders.
Clinical Trials Status at SCRI-CCCIT GesmbH ( Site 0371)
Currently, there are NaN active trials in "SCRI-CCCIT GesmbH ( Site 0371)".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in SCRI-CCCIT GesmbH ( Site 0371),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in SCRI-CCCIT GesmbH ( Site 0371), 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".